Ali Hazrati

1.3k total citations
49 papers, 937 citations indexed

About

Ali Hazrati is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Ali Hazrati has authored 49 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Infectious Diseases and 12 papers in Genetics. Recurrent topics in Ali Hazrati's work include Mesenchymal stem cell research (12 papers), Extracellular vesicles in disease (11 papers) and Vector-Borne Animal Diseases (10 papers). Ali Hazrati is often cited by papers focused on Mesenchymal stem cell research (12 papers), Extracellular vesicles in disease (11 papers) and Vector-Borne Animal Diseases (10 papers). Ali Hazrati collaborates with scholars based in Iran, United Kingdom and Canada. Ali Hazrati's co-authors include Kosar Malekpour, Sara Soudi, Seyed Mahmoud Hashemi, Majid Ahmadi, John A. Hartley, Leila Roshangar, Mohammad Mahmoudi, Michael Shipman, Lloyd R. Kèlland and Rajender S. Varma and has published in prestigious journals such as Nature, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Ali Hazrati

46 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Hazrati Iran 17 528 170 154 149 130 49 937
Jieying Liu China 21 527 1.0× 87 0.5× 169 1.1× 58 0.4× 67 0.5× 45 1.2k
Yuki Nakao Japan 14 414 0.8× 116 0.7× 157 1.0× 65 0.4× 90 0.7× 36 886
Tingting Ning China 18 725 1.4× 83 0.5× 240 1.6× 25 0.2× 183 1.4× 50 1.2k
Hiroko Hoshi Japan 17 613 1.2× 76 0.4× 140 0.9× 56 0.4× 131 1.0× 39 1.2k
Peter Vischer Germany 22 733 1.4× 33 0.2× 158 1.0× 69 0.5× 162 1.2× 44 1.2k
Alina Sesărman Romania 19 304 0.6× 144 0.8× 128 0.8× 20 0.1× 174 1.3× 43 991
Chiara Rampazzo Italy 23 950 1.8× 57 0.3× 71 0.5× 33 0.2× 156 1.2× 41 1.5k
Hajime Nakano Japan 18 434 0.8× 48 0.3× 79 0.5× 26 0.2× 198 1.5× 117 1.2k
Syahril Abdullah Malaysia 16 511 1.0× 85 0.5× 73 0.5× 19 0.1× 95 0.7× 53 901
Su‐Yeon Kim South Korea 14 215 0.4× 65 0.4× 35 0.2× 19 0.1× 122 0.9× 63 660

Countries citing papers authored by Ali Hazrati

Since Specialization
Citations

This map shows the geographic impact of Ali Hazrati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Hazrati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Hazrati more than expected).

Fields of papers citing papers by Ali Hazrati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Hazrati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Hazrati. The network helps show where Ali Hazrati may publish in the future.

Co-authorship network of co-authors of Ali Hazrati

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Hazrati. A scholar is included among the top collaborators of Ali Hazrati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Hazrati. Ali Hazrati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vakilian, Saeid, Ali Hazrati, Saeed Karima, et al.. (2025). Extracellular vesicles derived from MSCs carrying dexamethasone alleviate inflammatory damage in septic mice. European Journal of Pharmacology. 1005. 178042–178042.
2.
Rahimi, Ali, Ali Hazrati, Kosar Malekpour, et al.. (2025). Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota. Biomedicine & Pharmacotherapy. 186. 118014–118014. 8 indexed citations
3.
4.
Mardi, Amirhossein, Samaneh Abdolmohammadi‐Vahid, Sanaz Abbaspour‐Aghdam, et al.. (2024). Nanocurcumin modulates Th17 cell responses in moderate and severe COPD patients. Heliyon. 10(9). e30025–e30025. 3 indexed citations
5.
Hazrati, Ali, Kosar Malekpour, Hossein Khorramdelazad, Samira Rajaei, & Seyed Mahmoud Hashemi. (2024). Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules. Biomarker Research. 12(1). 35–35. 21 indexed citations
6.
7.
8.
Malekpour, Kosar, Ali Hazrati, Sara Soudi, & Seyed Mahmoud Hashemi. (2023). Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery. Journal of Controlled Release. 354. 755–769. 49 indexed citations
9.
Hazrati, Ali, Kosar Malekpour, Arezou Khosrojerdi, et al.. (2023). Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. Frontiers in Immunology. 14. 1280601–1280601. 12 indexed citations
10.
Malekpour, Kosar, Ali Hazrati, Arezou Khosrojerdi, Leila Roshangar, & Majid Ahmadi. (2023). An overview to nanocellulose clinical application: Biocompatibility and opportunities in disease treatment. Regenerative Therapy. 24. 630–641. 14 indexed citations
11.
Hazrati, Ali, Sara Soudi, Kosar Malekpour, et al.. (2022). Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications. Biomarker Research. 10(1). 30–30. 109 indexed citations
12.
Mosaddeghi-Heris, Reza, Milad Shirvaliloo, Sanaz Abbaspour‐Aghdam, et al.. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy. 13(1). 371–371. 69 indexed citations
13.
Hazrati, Ali, Kosar Malekpour, Sara Soudi, & Seyed Mahmoud Hashemi. (2022). CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations. Biomedicine & Pharmacotherapy. 156. 113943–113943. 47 indexed citations
14.
Abbaspour‐Aghdam, Sanaz, Ali Hazrati, Samaneh Abdolmohammadi‐Vahid, et al.. (2022). Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function. European Journal of Pharmacology. 933. 175267–175267. 15 indexed citations
15.
Lipsett, Mark, Ali Hazrati, Steven Paraskevas, et al.. (2003). Signals for death and differentiation: a two-step mechanism for in vitro transformation of adult islets of Langerhans to duct epithelial structures. Cell Death and Differentiation. 10(9). 987–996. 24 indexed citations
16.
Hazrati, Ali, et al.. (1981). Isolation and characterization of a bovine herpesvirus 3 From cases of calf pneumonia in Iran. SHILAP Revista de lepidopterología. 32(1). 21–35. 1 indexed citations
17.
Hazrati, Ali, et al.. (1975). The Isolation and Identification of Infectious Bovine Rhinotracheitis Virus in Iran. SHILAP Revista de lepidopterología. 27(1). 21–35. 2 indexed citations
18.
Mirchamsy, H. & Ali Hazrati. (1973). A review on aetiology and pathogeny of African horse sickness. SHILAP Revista de lepidopterología. 25(1). 23–46. 5 indexed citations
19.
Mirchamsy, H., et al.. (1970). Growth and Persistent Infection of African Horse-Sickness Virus in a Mosquito Cell Line. American Journal of Veterinary Research. 31(10). 1755–1762. 4 indexed citations
20.
Hazrati, Ali, et al.. (1965). SEROLOGIC STUDIES OF AFRICAN HORSE-SICKNESS VIRUS WITH EMPHASIS ON NEUTRALIZATION TEST IN TISSUE CULTURE.. PubMed. 29. 173–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jieying Liu Breakdown of academic impact, for papers by Yuki Nakao Breakdown of academic impact, for papers by Tingting Ning Breakdown of academic impact, for papers by Hiroko Hoshi Breakdown of academic impact, for papers by Peter Vischer Breakdown of academic impact, for papers by Alina Sesărman Breakdown of academic impact, for papers by Chiara Rampazzo Breakdown of academic impact, for papers by Hajime Nakano Breakdown of academic impact, for papers by Syahril Abdullah Breakdown of academic impact, for papers by Su‐Yeon Kim
Rankless by CCL
2026